Marinus Pharmaceuticals
MRNS50
$1.41arrow_drop_up1.43%$0.02
Penny Stock
MRNS50
$1.41
arrow_drop_up1.43%AI Deep-Learning Forecast (MRNS)
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Marinus Pharmaceuticals (MRNS) Stocklytics Forecast
Keep an eye on Marinus Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the analyst price prediction for Marinus Pharmaceuticals (MRNS) stock?
Analysts have set a target price of $25.22 for Marinus Pharmaceuticals (MRNS), based on forecasts from 27 analysts. The predicted price range extends from a high of $50 to a low of $13. This represents a potential increase of up to 3.45K% and a decrease of 821.99% from the current price of $1.41. These forecasts are as of 2020 Nov 25.
help
What are the analyst ratings for Marinus Pharmaceuticals (MRNS) stock?
The analyst ratings for Marinus Pharmaceuticals (MRNS) are distributed as follows: 1 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Marinus Pharmaceuticals .
help
What is the AI price prediction for Marinus Pharmaceuticals (MRNS) stock?
At present, there is no AI or machine-learning-based price prediction available for Marinus Pharmaceuticals (MRNS) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.